I see 4 and 5 being the bulk of the spend with the remaining funds. The rest is brain power. And if 4 and 5 prove successful then 7 gets ticked.
They are aiming for commercialization as soon as possible is what I understand from all the announcements and videos. This should reduce the likelihood of another CR. Also we dodged a 50% dilution from a farmout of Mbele. So still ahead on that metric so far.
"Bigger than anyone expected…" This is on loop in my head. They expected 15.7BCF and net pay zones are more than double the thickness they expected. I would sumize from this that the expectations have increased
And If lab results are as expected? Which has been touted by the directors Then Hopefully the SP rerate will blow HE1 out of the water like a dissolved Helium Molecule and CR's are in the rear view mirror
NHE Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
